✦ LIBER ✦

Regulatory issues in aging pharmacology

✍ Scribed by Franz F. Hefti; Roxanne Bales

Book ID: 111199290
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 87 KB
Volume: 5
Category: Article
ISSN: 1474-9718
DOI: 10.1111/j.1474-9726.2006.00193.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Issues in aging

✍ Service, Kathryn Pekala; Hahn, Joan Earle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Regulatory issues in CAM

✍ Cynthia A. Parkman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Regulatory issues in CAM

✍ Cynthia A. Parkman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Re: Regulatory Toxicology and Pharmacolo

Re: Regulatory Toxicology and Pharmacology, Volume 52, Issue 1, Supplement 1

✍ Paul Eger; Sanne Magnan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB

European Regulatory Issues in Nanomedici

European Regulatory Issues in Nanomedicine

✍ Giorgia Guerra 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 182 KB

Regulatory issues in cellular therapies

✍ Adrian P. Gee 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Cellular and gene therapies offer considerable promise as new treatment modalities. The Food and Drug Administration has been developing strategies to regulate these rapidly evolving fields in a manner that sustains progress and also ensures minimization of potential risks. The death of a patient on